|
VAMP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31079999998729E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03770000003944E-06 |
| Normal-vs-Stage2 |
1.788950E-01 |
| Normal-vs-Stage3 |
9.600300E-04 |
| Normal-vs-Stage4 |
6.337800E-02 |
| Stage1-vs-Stage2 |
1.765770E-01 |
| Stage1-vs-Stage3 |
6.023400E-01 |
| Stage1-vs-Stage4 |
4.667800E-02 |
| Stage2-vs-Stage3 |
3.610600E-01 |
| Stage2-vs-Stage4 |
9.557400E-01 |
| Stage3-vs-Stage4 |
2.090800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.03930000000274E-05 |
| Normal-vs-AfricanAmerican |
5.745800E-02 |
| Normal-vs-Asian |
2.833100E-04 |
| Caucasian-vs-AfricanAmerican |
6.293000E-01 |
| Caucasian-vs-Asian |
2.969400E-01 |
| AfricanAmerican-vs-Asian |
8.074200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.596100E-03 |
| Normal-vs-Female |
7.51860000036686E-07 |
| Male-vs-Female |
1.630220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.20779999998899E-06 |
| Normal-vs-Age(41-60Yrs) |
4.05049999999685E-05 |
| Normal-vs-Age(61-80Yrs) |
3.458100E-02 |
| Normal-vs-Age(81-100Yrs) |
7.632800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.887800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.558200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.324600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.734450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.615750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.379800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.950100E-04 |
| Classical-VS-Follicular |
2.06169999994454E-06 |
| Classical-VS-Other |
4.100800E-01 |
| Classical-VS-Normal |
8.74169958642312E-10 |
| Tall-VS-Follicular |
4.729200E-01 |
| Tall-VS-Other |
7.288000E-01 |
| Tall-VS-Normal |
2.890800E-01 |
| Follicular-VS-Other |
4.943000E-01 |
| Follicular-VS-Normal |
8.638800E-01 |
| Other-VS-Normal |
5.057000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.775500E-03 |
| Normal-vs-N1 |
4.602000E-03 |
| N0-vs-N1 |
5.360200E-01 |
|
|
